The precautionary principle: A double edged sword?

Cell and Tissue Banking

Volumn 11, Issue 3, 2010, Pages 217-224

  Kirkland, Mark ^a  

^a Geelong Bone Bank   (Australia)

Author keywords

CGMP; Precautionary principle; Regulation; Risk; VCJD

Indexed keywords

ARTICLE; CREUTZFELDT JAKOB DISEASE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL; LEGAL ASPECT; SOCIAL CONTROL;

CREUTZFELDT-JAKOB SYNDROME; DELIVERY OF HEALTH CARE; HUMANS; SOCIAL CONTROL, FORMAL; TISSUE BANKS; UNIVERSAL PRECAUTIONS;

EID: 77956791128     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-010-9182-8     Document Type: Article

References (21)

1. Abrahamson E (1996) Managerial fashion. Acad Manag Rev 21:254-285
2. Australian Code of Good Manufacturing Practice-Human Blood and Tissues (2000) In: Administration TG, ed. p. v
3. Barabara J, Flanagan P (1998) Blood transfusion risk: protecting against the unknown. BMJ 316:717-718.
4. Correll PK, Law MG, Seed CR et al (2001) Variant Creutzfeldt- Jakob disease in Australian blood donors: Estimation of risk and the impact of deferral strategies. Vox Sang 81:6-11.
5. Cox LA, Babayev D, Huber W (2005) Some limitations of qualitative risk rating systems. Risk Anal 25:651-662
6. Dauer AE (1996) Investing in regulatory quality. In: Dauer EA (ed) Blood banking and regulation: procedures, problems, and alternatives. National Academy Press, Washington,DC.
7. Dzik S (2002) Non-infectious serious hazards of transfusion. Blood News p. 12/11/2008
8. Farrugia A (2000) When do tissues become products-regulatory oversight of emerging biological therapies. Cell Tissue Bank 7:325-335.
9. Hergon E, Moutel G, Duchange N, Bellier L, Rouger P, Herve C (2005) Risk management in transfusion after the HIV blood contamination crisis in France: the impact of the precautionary principle. Trans Med Rev 19:273-280
10. Jacob M, Hellstrom T (2000) Policy understanding of science, public trust and the BSE-CJD crisis. J Hazard Mater 78:303-317
11. Kuhn T (1996) The structure of scientific revolutions, 3rd edn. University of Chicago Press, Chicago
12. Miller H, Conko G (2000) The protocols illusory principle. Nature Biotech 18:360
13. Miller H, Conko G (2001) Precaution without principle. Nature Biotech 119:302-303
14. Rapport annuel (1998) Jurisprudence et avis de 1997. Réflexion sur le droit de la santé. In: dTEtat C, ed
15. Ratzan S (1999) Editorial: strategic health communication and social marketing on risk issues. J Health Comm 4:1-6
16. Reynolds E, Wickenden C, Oliver A (2001) The impact of improved safety on maintaining a sufficient blood supply. Transfus Clin Biol 8:235-239
17. Seitz R, von Auer F, Blümel J et al (2007) Impact of vCJD on blood supply. Biologicals 35:79-97
18. St Romaine C, Hazlehurst G, Jewell AP (2004) Leucodepletion for transmissible spongiform encephalopathies. Br J Biomed Sci 61:48-54
19. Statement by the UK Spongiform Encephalopathy Advisory Committee (1996)
20. Williamson L (2000). The serious hazards of transfusion (SHOT) initiative: the UK approach to haemovigilance. Vox Sang 78:291-295
21. Wilson K, Wilson M, Hébert P, Graham I (2003) The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy. Transfus Med Rev 17:89-94 Decision theory http://en.wikipedia.org/wiki/Decision-theory.